pharmaphorum July 22, 2024
Phil Taylor

Scientists in the US have developed a new universal form of influenza vaccine that they say could protect against all strains of the virus – and do away with the annual scramble to match shots to circulating flu strains.

The team led by researchers at Oregon Health & Science University (OHSU) think their ‘one and done’ model – which uses a cytomegalovirus (CMV) vector – could confer lifetime immunity against the evolving virus.

While still in the animal testing stage, initial results published in Nature Communications have been promising against H5N1, a bird flu strain that is a frontrunner to cause a new pandemic.

In the past few years, a highly pathogenic strain of H5N1 has emerged that can jump...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID, Trends
Understanding the Growing Impact of Obesity in the United States
Wearable electrical nerve stimulation device eases long COVID pain and fatigue, say researchers
Transforming public health: a physician’s innovative approach [PODCAST]
Trump Nominates Physicians for CDC Director, Surgeon General
5 Things You Should Know About Long COVID

Share This Article